S9788 modulation of P-glycoprotein- and multidrug-related protein-mediated multidrug resistance by servier 9788 in doxorubicin-resistant MCF7 cells

Biochemical Pharmacology

Volumn 56, Issue 4, 1998, Pages 497-502

  Bichat, Francis ^a   Solis Recendez, Guadalupe ^a   Poullain, Marie Gwenaelle ^c   Poupon, Marie France ^b   Khayat, David ^a   Bastian, Gerard ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT CURIE   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Doxorubicin resistance; MCF7; MDR; MDR sensitization; MRP

Indexed keywords

2,4 BIS(ALLYLAMINO) 6 [4 [[2,2 BIS(4 FLUOROPHENYL)ETHYL]AMINO]PIPERIDINO] 1,3,5 TRIAZINE; DOXORUBICIN; GLYCOPROTEIN P;

ARTICLE; BREAST CANCER; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; DRUG SENSITIZATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ANTIBIOTICS, ANTINEOPLASTIC; ATP-BINDING CASSETTE TRANSPORTERS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PIPERIDINES; RHODAMINE 123; RHODAMINES; TRIAZINES; TUMOR CELLS, CULTURED;

EID: 0031782105     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00007-0     Document Type: Article

References (22)

1. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 62:1993;385-427.
2. Zaman G.J.R., Flens M.J., Van Leusden M.R., De Haas M., Mulder H.S., Lankelma J., Pinedo H.M., Scheper R.J., Baas F., Broxterman H.J., Borst P. The human multidrug resistance-associated protein MRP is a plasma membrane drug efflux pump. Proc Natl Acad Sci USA. 91:1994;8822-8826.
3. Ford J.M., Hait W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev. 42:1990;155-199.
4. Arvelo F., Poupon M.F.P., Bichat F., Grossin F., Bourgeois Y., Jacrot R., Bastian G., Le Chevalier T. Adding a reverser verapamil to combined chemotherapy overrides resistance in small cell lung cancer xenografts. Eur J Cancer. 31A:1995;1862-1868.
5. Julia A.M., Roché H., Berlion M., Lucas C., Milano G., Bizzari J.P., Canal P. Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro definition of the optimal schedule and comparison with verapamil . Br J Cancer. 69:1994;868-874.
6. Pierre A., Dunn T.A., Kraus-Berthier L., Leonce S., Saint-Dizier D., Regnier G., Dhainaut A., Berlion M., Bizzari J.P., Atassi G. In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative. Invest New Drugs. 10:1992;137-148.
7. Hill B.T., Van der Graaf W.T.A., Hosking L.K., De Vries E.G.E., Mulder N.H., Whelan R.D.H. Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro. Int J Cancer. 55:1993;330-337.
8. Bichat F., Mouawad R., Solis-Recendez M.G., Khayat D., Bastian G. Cytoskeleton alteration in MCF7R cells, a multidrug resistant human breast cancer cell line. Anticancer Res. 17:1997;3393-3401.
9. Legrand O., Perrot J.Y., Tang R.P., Simonin G., Gurbuxani S., Zittoun R., Marie J.P. Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Br J Haematol. 94:1996;23-33.
10. Ferry D.R., Russell M.A., Cullen M.H. P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is allosterically coupled to a vinca-alkaloid selective binding site. Biochem Biophys Res Commun. 188:1992;440-445.
11. Mossmann T. Rapid coloration assay for cellular growth and survival application to proliferation and cytotoxicity assays . J Immunol Methods. 65:1983;55-63.
12. Robert J. Extraction of anthracyclins from biological fluid for HPLC evaluations. J Liq Chromatography. 3:1980;1561-1572.
13. Fisher-Szafarz B., Szafarz D., De Murillo A.G. A general, fast and sensitive micromethod for DNA determination application to rat and mouse liver, rat hepatoma, human leukocytes, chicken fibroblats, and yeast cells . Anal Biochem. 110:1981;165-170.
14. Stein U., Walther W., Lemm M., Naudorf H., Fichtner I. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo. Int J Cancer. 72:1997;885-891.
15. Versantvoort C.H.M., Broxterman H.J., Bagrij T., Scheper R.J., Twentyman P.R. Regulation by gluthation of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer. 72:1995;82-89.
16. Cass C.E., Janawska-Wieczorek A., Lynch M.A., Sheinin H., Hindenbuerg A.A., Beck W.T. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines. Cancer Res. 49:1989;5788-5804.
17. Keizer H.G., Schuurhuis G.J., Broxterman H.J., Lankelma J., Schoonen W.G.E.J., Van Rijn J., Pinedo H.M., Joenje H. Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung cancer cells. Cancer Res. 49:1989;2988-2993.
18. Leonce S., Pierre A., Anstett M., Perez V., Genton A., Bizzari J.P., Atassi G. Effect of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance. Biochem Pharmacol. 44:1992;1707-1715.
19. Gervanosi J.E., Fields S.Z., Krishna S., Baker M.A., Rosado M., Thuraisamy K., Hindenburg A.A., Taub R.N. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug resistant cell lines using laser-assisted confocal microscopy. Cancer Res. 51:1991;4955-4963.
20. Chauffert B., Martin F., Caignard A., Jeannin J.F., Leclerc A. Cytofluorescence localization of adriamycin in resistant colon cancer cells. Cancer Chemother Pharmacol. 13:1984;14-18.
21. Perez V., Pierre A., Leonce S., Anstett M., Atassi G. Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin. Anticancer Res. 13:1993;985-990.
22. Abbaszadegan M.R., Cress A.E., Futscher B.W., Bellamy W.T., Dalton W.S. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers. Cancer Res. 56:1996;5435-5442.